Bellerophon Therapeutics Inc (NASDAQ:BLPH)
| 1.75 BATS BZX Real-Time Price As of 9:30am ET |  -0.075 / -4.11%Today’s Change | 0.67 Today|||52-Week Range 3.50 | +94.44% Year-to-Date |
Latest BLPH News | Press Releases
No recent news for Bellerophon Therapeutics Inc.
Today’s Trading
| Previous close | 1.83 |
| Today’s open | 1.75 |
| Day’s range | 1.75 - 1.75 |
| Volume | 351 |
| Average volume (3 months) | 745,901 |
| Market cap | $22.5M |
Data as of 9:30am ET, 02/02/2023
Growth & Valuation
| Earnings growth (last year) | +41.08% |
| Earnings growth (this year) | -12.07% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.04 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| APMAptorum Group Ltd | -0.32 | -6.61% |
| CEMIChembio Diagnostics ... | -0.00 | -0.36% |
| ---- | ||
| NNVCNanoViricides Inc | +0.07 | +5.15% |
Data as of 11:00am ET, 02/02/2023
Financials
| Next reporting date | March 16, 2023 |
| EPS forecast (this quarter) | -$0.48 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$17.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Warren, New Jersey |
Forecasts
